Standard concurrent chemoradiotherapy (CCRT) for cervical cancer achieves disease-free survival (DFS) in approximately 70% of patients with locally advanced disease; however, nearly 30% still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback